$CYIO More official PR will be released shortly, however I can confirm that the definitive agreement has now been signed with our new JV partner.
This positions CYIO to enter a significant market opportunity within the fast-growing health and wellness sector.
Importantly, the structure gives CYIO control across the full process — from manufacturing through to distribution — with revenues and funds managed through the CYIO-controlled U.S. distribution platform.
This is not a concept or startup product. The products are already established and selling in international markets, with the focus now on scaling into the U.S. market.
A major step forward for CYIO.
$CYIO More official PR will be released shortly, however I can confirm that the definitive agreement has now been signed with our new JV partner.
This positions CYIO to enter a significant market opportunity within the fast-growing health and wellness sector.
Importantly, the structure gives CYIO control across the full process — from manufacturing through to distribution — with revenues and funds managed through the CYIO-controlled U.S. distribution platform.
This is not a concept or startup product. The products are already established and selling in international markets, with the focus now on scaling into the U.S. market.
$CYIO On the ground today visiting 1 of 4 warehouses supporting our new JV partner’s distribution in Australia.
Real product. Real supply. Real scale.
Now imagine this in the U.S. 🇺🇸
$CYIO – New beginnings
The U.S. market continues to present one of the largest growth opportunities globally for established consumer brands.
In health, wellness, and plant-based categories, demand is accelerating rapidly — and so is competition.
Major global players and well-funded brands are actively competing for market share, validating just how significant this space has become.
Massive, fast-growing market:
Global:
• ~$6B → $15B–$20B+
• ~15–17% CAGR
U.S.:
• ~$1B+
• Rapid growth
An additional advantage exists where brands already have established distribution partners in other markets, particularly where those same groups or aligned networks operate within the U.S.
This creates a unique position to accelerate entry and scale, leveraging existing relationships rather than starting from zero.
$CYIO is pleased to provide an update on the ongoing audit process.
Our auditor has confirmed that work relating to FY2024 and Q1 2025 has now been completed, representing a significant step forward in the overall audit program. A follow-up meeting is scheduled at the end of the month to review progress and confirm next steps toward completion.
The Company continues to progress through its two-year PCAOB-compliant audit, which remains on track for completion by June 2026.
This process is focused on strengthening the Company’s financial reporting standards, enhancing transparency, and aligning CYIO with higher levels of market compliance.
$CYIO confirms the Pink Yield sign has now been removed on OTC Markets following a minor administrative update.
The issue related to a document date has been resolved.
$CYIO confirms a meeting has been scheduled with the Company’s auditor next week to review progress and timing for completion of the two-year audit.
We remain focused on advancing the audit process and will provide updates as available.
$CYIO Update
We have scheduled our 2-year audit review meeting with our auditor on May 5th as we progress toward full PCAOB audit completion.
This is a key step in finalising both audit periods and aligning CYIO for its planned uplisting.
Current timing remains on track, with completion targeted to support an uplisting during 2026.
We will continue to provide updates as milestones are achieved.
$CYIO | A Strategic Shift
At CYIOS Corporation, we are actively evolving.
Medical supplies have provided a strong foundation —
but they are also:
• Capital intensive
• Operationally heavy
• Typically low margin
The focus now is clear:
➡ Diversifying into higher-margin opportunities
➡ Targeting faster-growing global markets
➡Prioritising scalable, distribution-led business models
This is a strategic repositioning toward growth and profitability.
One Such Opportunity… A major shift is underway.
The global move toward plant-based nutrition and functional beverages isn’t slowing — it’s accelerating.
What was once niche is now becoming mainstream consumer behaviour.
• Global categories scaling into the tens of billions
• Coconut and functional hydration among the fastest-growing segments
• Driven by health, sustainability, and changing dietary habits
Plant-based + functional drinks = booming globally.
But the U.S. is still early — and that’s where categories explode.
We’re positioning ahead of that shift.
$CYIO Appreciate the support from Dave Donlin and the coverage on CYIO.
👉 View Dave’s LinkedIn post
The FY2025 results mark an important shift for the Company, moving from loss to profitability and reflecting the work done to improve operational efficiency and financial discipline.
• Revenue: ~$11.9M
• Gross Profit: ~$1.58M
• Net Income: ~$497K
At the same time, we continue to focus on simplifying the structure, strengthening reporting standards, and positioning the business appropriately.
Thanks again Dave — appreciate the support and engagement.
$CYIO Financial Update – FY2025
CYIO has delivered a significant turnaround in FY2025,
Revenue increased to $11.9M, up from $8.0M in the prior year.
Focused on simplifying structure and managing liabilities.
As part of ongoing financial discipline, CYIO will focus its reporting on operations where it has full visibility and control, ensuring consistency and reliability of disclosed financial information.
CYIO$ confirms OTCIQ access has been restored following execution of the Issuer Services Agreement.
We are open for business.
Financials are next to be posted.
$CYIO Year-end financials are now complete and, subject to final sign-off, the results are looking strong — particularly given current global market conditions.
Full release shortly.
#CYIO#OTCMarkets#Update
$CYIO have been informed that year-end financials are now completed and currently undergoing final legal review prior to release.
This represents a key step forward as the company continues to progress across multiple fronts:
• Financial reporting now aligned and ready for publication
• Legal sign-off underway to ensure full compliance
• Positioning for removal of the Yield Sign
• Continued progress toward OTCQBuplisting pathway
• Audit progression with Year 2 of the Public Company Accounting Oversight Board process commencing
$CYIO Over the coming weeks, multiple key milestones are aligning to support a clear and scalable growth narrative:
• 2025 Financials
Year-end financials scheduled for release by April 15
Reflecting strong performance under current global market conditions
• Audit Progress
Year 1 of the two-year Public Company Accounting Oversight Board audit completed
Year 2 now commencing — a major step toward higher market tiering
• Uplisting Pathway
Defined plan targeting OTCQB uplisting by July 2026
Driving improved liquidity and broader investor access
• U.S. Expansion (Major Catalyst)
Entry into a large and rapidly growing U.S. market via an established platform
→ Existing supply chain
→ Proven demand
→ Early retail momentum
This is execution — not speculation.
• Strategic Funding Alignment
Funding partners engaged to support rollout and accelerate scale
• OTC Status Improvement
Removal of the Yield Sign expected as filings are brought current — a key signal of compliance and progress
• New Website Launch
Updated corporate website in final stages — improving transparency, communication, and investor access
$CYIO The U.S. market is undergoing a major shift toward new categories of consumer demand — and CYIO is positioning itself to capitalize on it.
Our next phase of growth is focused on sectors driven by long-term structural changes in consumer behaviour. These are not short-term trends — this is embedded demand that continues to accelerate.
In several of these sectors, the U.S. is still in the early stages of adoption, creating a significant market penetration opportunity — exactly where CYIO is focused.
We are targeting opportunities with:
– Established operations
– Proven products with repeat customers
– Existing manufacturing and supply chains
– Early retail and distribution momentum
This is where we see asymmetric upside.
#CYIO #Opportunity #Scaling #OTCMarkets #Investors #HealthyLifestyle
$CYIO, Pen has been put to paper — a Heads of Agreement has now been signed.
This marks a significant first step toward what we believe is a major opportunity for CYIO in 2026. It lays the foundation for establishing our footprint in the U.S. retail market while advancing our broader strategy of scaling the business and positioning toward stronger exchanges.
This is only the beginning — more details on the agreement, our partner, and why we believe this will be a game changer for CYIO will be shared as soon as we are able.
#CYIO #Growth #OTCMarkets #Expansion
$CYIO moving forward:
We’re meeting with our JV partner next week following his return from Jakarta, Vietnam & Malaysia to sign the Heads of Agreement.
Following a full review of manufacturing and supply chain, we’re also looking to expand the existing product line.
This unlocks access to some of the largest retail outlets in the U.S., with early discussions already looking very strong.
Year-end financials will be submitted to legal this week and uploaded to OTC Markets shortly after.
Bullish on 2026. Strong momentum, focused execution — and plenty more to come.
#CYIO #Growth #OTCMarkets #Expansion #InvestingTips
$CYIO; A key strategic advantage for CYIO’s expansion plans is the Australia–USA trade relationship.
Thanks to the Australia–US Free Trade Agreement, many Australian products can enter the U.S. with minimal or zero import tariffs, creating a powerful edge.
Similar imports from China, India, Vietnam and other parts of Asia can face higher duties and regulatory hurdles.
Smart trade positioning matters when scaling globally.
#CYIO #Growth #GlobalExpansion #TradeAdvantage